Key result
Acute STEMI linked to greater myocardial inflammation and tissue damage proteins than Takotsubo syndrome in women.
Observational (n=36)
Proteomic profiling reveals distinct inflammatory and tissue damage protein signatures that differentiate STEMI from Takotsubo syndrome in women, highlighting ADIPOQ and other proteins as potential diagnostic biomarkers.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for protein-based differentiation of STEMI versus Takotsubo in women; leaves open diagnostic or therapeutic utility pending validation.
BACKGROUND: ST-elevation myocardial infarction (STEMI) and Takotsubo syndrome (TS) are two distinct cardiac conditions that both result in sudden loss of cardiac dysfunction and that are difficult to distinguish clinically. This study compared plasma protein changes in 24 women with STEMI and 12 women with TS in the acute phase (days 0-3 post symptom onset) and the stabilization phase (days 7, 14, and 30) to examine the molecular differences between these conditions. METHODS: Plasma proteins from STEMI and TS patients were extracted during the acute and stabilization phases and analyzed via quantitative proteomics. Differential expression and functional significance were assessed. Data are accessible on ProteomeXchange, ID PXD051367. RESULTS: During the acute phase, STEMI patients showed higher levels of myocardial inflammation and tissue damage proteins compared to TS patients, along with reduced tissue repair and anti-inflammatory proteins. In the stabilization phase, STEMI patients exhibited ongoing inflammation and disrupted lipid metabolism. Notably, ADIPOQ was consistently downregulated in STEMI patients in both phases. When comparing the acute to the stabilization phase, STEMI patients showed increased inflammatory proteins and decreased structural proteins. Conversely, TS patients showed increased proteins involved in inflammation and the regulatory response to counter excessive inflammation. Consistent protein changes between the acute and stabilization phases in both conditions, such as SAA2, CRP, SAA1, LBP, FGL1, AGT, MAN1A1, APOA4, COMP, and PCOLCE, suggest shared underlying pathophysiological mechanisms. CONCLUSIONS: This study presents protein changes in women with STEMI or TS and identifies ADIPOQ, SAA2, CRP, SAA1, LBP, FGL1, AGT, MAN1A1, APOA4, COMP, and PCOLCE as candidates for further exploration in both therapeutic and diagnostic contexts.
No takes yet. Share an insight, caveat, or question.
Hussain et al. (2024) conducted an observational in ST-Elevation Myocardial Infarction and Takotsubo Syndrome (n=36). ST-Elevation Myocardial Infarction vs. Takotsubo syndrome was evaluated on Plasma protein changes. Women with STEMI showed higher levels of myocardial inflammation and tissue damage proteins in the acute phase compared to women with Takotsubo syndrome, with ADIPOQ consistently downregulated.
Synapse has enriched 10 related papers. Consider them for comparative context: